Intended use, and why a label is not enough

Under FDA regulations, a product's intended use is not simply what its label says. FDA's regulation on the meaning of intended uses, 21 CFR 201.128, says the phrase refers to the objective intent of the persons legally responsible for a product's labeling. That intent can be shown by what they say, by the product's design or composition, and by the circumstances in which the product is distributed.

For a store that labels its products for research use only, this matters because the label is only one piece of evidence. Your product pages, your advertising and the way you sell all count as well.

What 21 CFR 201.128 says, in plain language

Section 201.128 sits in FDA's drug labeling regulations and explains what "intended uses" means where that phrase appears in those rules. In summary:

• Intended use means objective intent. It is judged from evidence, not from what a seller privately meant.
• That intent can be shown by the statements of the people responsible for the labeling, by the product's design or composition, or by the circumstances surrounding its distribution.
• The regulation gives examples of evidence: labeling claims, advertising matter, and oral or written statements by those people or their representatives.
• Intent can also be shown where, with their knowledge, a product is offered or used for a purpose for which it is neither labeled nor advertised.
• Intended uses can change after a product enters interstate commerce. If a packer, distributor or seller intends a different use, that person is required to provide labeling suited to the new use.

The regulation also contains a narrow provision about approved drugs and prescribing by health care providers, which is outside the scope of this page.

FDA's device regulations contain a parallel provision, 21 CFR 801.4. FDA's guidance on research-use-only diagnostic products cites it when explaining intended use.

Objective intent, explained

"Objective" is the key word. Under the regulation, intent is read from evidence: what you say, what you sell and how you sell it. FDA's guidance on research-use-only diagnostic products describes this as looking at the totality of the circumstances surrounding a product's distribution.

So the question is not only "what does the label say?" It is "what does everything about this product and this business, taken together, show it is for?"

Why a label is not enough

FDA's research-use-only guidance is written for in vitro diagnostic products, but it shows how the agency applies the intended use idea to a label. It states that merely placing a research-use-only label on a product does not exempt it from requirements that would otherwise apply, and that FDA may decide a product's intended use from other evidence, including how it is marketed. It also says overt statements in labeling and advertising may be enough on their own to show that a product is really intended for something other than research.

Put simply, a label states a position. Everything else on your site either supports it or undermines it. A label that says one thing while a blog post, an email or a product name says another does not make the other material disappear. Our explainer on what research use only means covers the label itself in more detail.

Where intent shows up in an online store

Using the regulation's categories, these are places in a typical online store where evidence of intended use can appear.

Labeling and product pages

• Product names, descriptions and images.
• Inserts, certificates and documents shipped with or linked from the product.
• Category names, menus and search filters.

Advertising and promotion

• Email campaigns, discount banners and landing pages.
• Social media posts and paid ads.
• Content published by affiliates or others acting for you. See affiliate and influencer programs for research suppliers.

Oral and written statements

• Live chat transcripts and customer service emails.
• FAQ answers and blog posts, including old ones that are still published.
• Statements made by staff, sales representatives or anyone speaking for the business.

Circumstances of distribution

• Who you market to and who actually buys from you.
• Other items you sell alongside your products, and what they suggest about how the products will be used.
• What you know about how buyers use what they buy.

Keeping the evidence consistent

Because intent is judged from the whole picture, the useful work is making the whole picture consistent:

1. Write one sentence that says who you sell to and for what purpose, and make sure your whole team can repeat it.
2. Review every product page against that sentence.
3. Remove copy that describes uses other than laboratory research. Our list of claims to remove from a research supply store is a starting point.
4. Check channels you do not look at every day: email archives, social accounts, affiliate pages and old blog posts.
5. Make sure checkout, terms and order emails state the same purpose and buyer type.
6. Train anyone who answers customers not to give advice about uses outside research.
7. Recheck on a schedule, because copy drifts as products and promotions change.

Buyer declarations do not change your own statements

Declarations by buyers, such as a site-entry check or a signed statement at checkout, record what the buyer told you. FDA's research-use-only guidance describes buyer certification programs as one factor among the circumstances, and says such a program alone does not relieve the seller of responsibility for keeping labeling and distribution practices consistent with the label. The same logic applies to your own copy: a buyer's declaration does not cancel out a claim you made.

Claddr's weekly monitoring checks product pages, policies and checkout copy against your compliance profile and flags the exact line with a suggested fix, and its audit record stores buyer checks and signatures against each order. These help you keep records and spot drift. They do not determine how any product is regulated.

The limits of this page

This is a plain-language summary of one regulation and related FDA guidance. It does not tell you how FDA would view your products or your business. Speak to a qualified lawyer about your business, particularly before relying on a label to describe what you sell.